Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Institut Merieux

Headquarters: Lyon, France
Year Founded: 1897
Status: Private

BioCentury | Dec 5, 2020
Management Tracks

CureVac hires GSK Vaccines veteran Blanc as CBO and chief commercial officer; plus moves at Spero, 4D, Transgene, Achilles and Datavant

mRNA play CureVac N.V. (NASDAQ:CVAC) hired Antony Blanc as CBO and chief commercial officer. Blanc most recently was managing director at Clarentis s.r.l., and prior to that VP, global
BioCentury | Oct 24, 2016
Financial News

Transgene proposes rights offering

BioCentury | May 19, 2016
Finance

Found in translation

Venture backing and infrastructure give Europe's biotech sector a chance to grow
BioCentury | Jan 11, 2016
Financial News

Transgene financial update

BioCentury | Nov 9, 2015
Financial News

ElsaLys Biotech completes venture financing

BioCentury | Jul 13, 2015
Company News

Transgene cancer, infectious news

BioCentury | Nov 10, 2014
Financial News

Merieux Developpement financial update

BioCentury | Nov 5, 2014
Financial News

Merieux closes EUR150M healthcare fund

BioCentury | Mar 31, 2014
Financial News

Transgene completes rights offering

Items per page:
1 - 10 of 22